• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用哌甲酯透皮系统治疗的注意力缺陷多动障碍患儿健康相关生活质量改善及药物满意度的时间进程和预测因素

Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system.

作者信息

Frazier Thomas W, Weiss Margaret, Hodgkins Paul, Manos Michael J, Landgraf Jeanne M, Gibbins Christopher

机构信息

Center for Pediatric Behavioral Health and Center for Autism Children's Hospital, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

J Child Adolesc Psychopharmacol. 2010 Oct;20(5):355-64. doi: 10.1089/cap.2009.0092.

DOI:10.1089/cap.2009.0092
PMID:20973706
Abstract

OBJECTIVE

The aim of this study was to evaluate the time course and predictors of improvement in health-related quality of life (HRQL) and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder (ADHD) and treated with the methylphenidate transdermal system (MTS).

METHODS

Temporal relationships between ADHD symptoms, medication satisfaction, and HRQL measures were examined via latent growth curve, structural path, and growth mixture models.

RESULTS

Higher levels of medication satisfaction at the end of titration predicted greater increases in family HRQL (p=0.004) and, to a lesser extent, child HRQL (p=0.068) throughout the study. At 4 of 6 (p<0.05) and 5 of 6 (p<0.10) contemporaneous time points, ADHD symptoms predicted child HRQL. At 2 of 6 (p<0.05) and 3 of 6 (p<0.10) contemporaneous time points, ADHD symptoms predicted family HRQL. ADHD did not predict child or family HRQL improvements at subsequent time points. A uniform pattern of change for child HRQL was noted, with most HRQL change following the pattern of symptom change during titration. Three distinct patterns of change were noted for family HRQL.

CONCLUSIONS

In most cases, medication satisfaction, ADHD symptoms, and HRQL improved simultaneously, suggesting that HRQL was not a delayed response to improvement in symptoms. Children showed a uniform pattern of improvement in HRQL that followed symptom change; three distinct patterns of change were found for improvement in family HRQL.

摘要

目的

本研究旨在评估诊断为注意力缺陷多动障碍(ADHD)并使用哌甲酯透皮系统(MTS)治疗的儿童,其健康相关生活质量(HRQL)改善的时间进程及预测因素,以及药物满意度情况。

方法

通过潜在增长曲线、结构路径和增长混合模型,研究ADHD症状、药物满意度和HRQL测量指标之间的时间关系。

结果

在滴定结束时较高的药物满意度预示着在整个研究过程中家庭HRQL有更大的提升(p = 0.004),在较小程度上也预示着儿童HRQL的提升(p = 0.068)。在6个同期时间点中的4个(p < 0.05)以及6个中的5个(p < 0.10)时间点,ADHD症状可预测儿童HRQL。在6个同期时间点中的2个(p < 0.05)以及6个中的3个(p < 0.10)时间点,ADHD症状可预测家庭HRQL。ADHD在后续时间点并不能预测儿童或家庭HRQL的改善情况。观察到儿童HRQL有统一的变化模式,大多数HRQL变化遵循滴定期间症状变化的模式。家庭HRQL则观察到三种不同的变化模式。

结论

在大多数情况下,药物满意度、ADHD症状和HRQL同时改善,这表明HRQL并非对症状改善的延迟反应。儿童在HRQL方面呈现出与症状变化一致的统一改善模式;家庭HRQL的改善发现了三种不同的变化模式。

相似文献

1
Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system.使用哌甲酯透皮系统治疗的注意力缺陷多动障碍患儿健康相关生活质量改善及药物满意度的时间进程和预测因素
J Child Adolesc Psychopharmacol. 2010 Oct;20(5):355-64. doi: 10.1089/cap.2009.0092.
2
HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.ADHD 患儿接受哌醋甲酯透皮贴剂治疗后的 HRQL 和药物满意度。
Curr Med Res Opin. 2009 Dec;25(12):3001-10. doi: 10.1185/03007990903388797.
3
Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.哌甲酯治疗的注意缺陷多动障碍儿童的健康相关生活质量:来自台湾样本的结果。
Aust N Z J Psychiatry. 2007 Dec;41(12):998-1004. doi: 10.1080/00048670701689451.
4
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍的儿童和青少年的健康相关生活质量。
Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844.
5
Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.丁螺环酮与哌甲酯治疗儿童注意力缺陷/多动障碍的随机双盲研究
Acta Med Iran. 2012;50(11):723-8.
6
A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/hyperactivity disorder.一项关于哌甲酯透皮系统治疗被诊断为注意力缺陷/多动障碍青少年的耐受性和有效性的为期6个月的开放标签扩展研究。
J Child Adolesc Psychopharmacol. 2010 Oct;20(5):365-75. doi: 10.1089/cap.2009.0122.
7
Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.从阿托莫西汀转换为奥洛他定(®)哌甲酯对 ADHD 儿童和青少年有效。
Expert Rev Neurother. 2011 Apr;11(4):499-508. doi: 10.1586/ern.11.18.
8
A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.一项针对患有注意力缺陷多动障碍(ADHD)儿童的哌甲酯透皮系统的随机、双盲、安慰剂对照实验室课堂评估。
J Atten Disord. 2006 Feb;9(3):476-85. doi: 10.1177/1087054705284089.
9
Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.在三种注意缺陷多动障碍(ADHD)亚型中,对于速释型哌甲酯依从性差的患者,渗透型口服系统哌甲酯疗效更佳。
Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.
10
Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.透皮哌甲酯、行为疗法及联合治疗用于多动症儿童
Exp Clin Psychopharmacol. 2005 May;13(2):111-26. doi: 10.1037/1064-1297.13.2.111.

引用本文的文献

1
ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder.注意力缺陷多动障碍与药物治疗:过去、现在与未来:注意缺陷多动障碍药物治疗格局变迁综述
Ther Innov Regul Sci. 2015 Sep;49(5):632-642. doi: 10.1177/2168479015599811.
2
Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS).经皮治疗注意缺陷多动障碍的哌醋甲酯贴片(MTS)。
CNS Drugs. 2014 Mar;28(3):217-28. doi: 10.1007/s40263-014-0141-y.
3
Incremental validity of neuropsychological assessment in the identification and treatment of youth with ADHD.
神经心理学评估在识别和治疗青少年 ADHD 中的增量有效性。
Clin Neuropsychol. 2014;28(1):26-48. doi: 10.1080/13854046.2013.863978. Epub 2013 Dec 17.
4
Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.基于汇总分析的托莫西汀治疗注意缺陷多动障碍儿童及青少年健康相关生活质量改善的预后因素
Atten Defic Hyperact Disord. 2014 Mar;6(1):25-34. doi: 10.1007/s12402-013-0119-5. Epub 2013 Oct 20.
5
The role of neuropsychological assessment in the functional outcomes of children with ADHD.神经心理学评估在 ADHD 儿童功能结局中的作用。
Neuropsychol Rev. 2012 Mar;22(1):54-68. doi: 10.1007/s11065-011-9185-7. Epub 2011 Nov 15.
6
An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence.一项关于 ADHA 患者每日一次使用改性释放哌醋甲酯的观察性研究:生活质量、治疗满意度和治疗依从性。
Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S257-65. doi: 10.1007/s00787-011-0203-3.
7
Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD.生活质量与精神病理特征之间的关系:来自 ADHD 患儿观察性研究的数据。
Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S267-75. doi: 10.1007/s00787-011-0204-2.